PHARMACANN INC.

Profile

Company Names

PHARMACANN INC.
PHARMACANN LLC

Addresses

190 SOUTH LASALLE STREET, 29TH FLOOR, CHICAGO, IL 60603

190 SOUTH LASALLE STREET, SUITE 2950, CHICAGO, IL 60603

190 SOUTH LASALLE, 29TH FLOOR, CHICAGO, IL 60603

1010 LAKE STREET, SECOND FLOOR, OAK PARK, IL 60302

1140 LAKE STREET, SUITE 304, OAK PARK, IL 60302

137 N. OAK PARK AVE., SUITE 101F, OAK PARK, IL 60301

Phone Numbers

888-493-6066
312-667-6231
7089195641
708-919-5641
708-369-8281

 

Entity Type:

CORPORATION

Industry:

OTHER, PHARMACEUTICALS

Year Incorporated:

2014

State Incorporated:

ILLINOIS

Total Amount Raised:

$508,407,765.00

Number of Funding Rounds:

18
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
18
2024-03-28 
$35,000,000.00 
$50,000,000.00 
$15,000,000.00 
Equity, Debt 
17
2023-12-01 
$10,000,000.00 
$10,000,000.00 
$0.00 
Debt 
16
2023-11-07 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
15
2023-11-06 
$10,000,000.00 
$10,000,000.00 
$0.00 
Debt 
14
2023-04-27 
$7,000,000.00 
$7,000,000.00 
$0.00 
Debt 
13
2023-04-03 
$12,911,111.00 
$18,000,000.00 
$5,088,889.00 
Debt 
12
2022-10-31 
$2,200,000.00 
$25,000,000.00 
$22,800,000.00 
 
11
2022-06-30 
$25,000,000.00 
$25,000,000.00 
$0.00 
Debt 
10
2021-06-24 
$85,000,000.00 
$85,000,000.00 
$0.00 
Debt 
9
2021-06-14 
$110,392,371.00 
$110,392,371.00 
$0.00 
 
8
2021-03-05 
$31,854,776.00 
$33,000,000.00 
$1,145,224.00 
Equity 
7
2020-09-10 
$35,941,298.00 
$35,941,298.00 
$0.00 
Equity 
6
2020-05-14 
$27,733,613.00 
$27,733,613.00 
$0.00 
Debt 
5
2020-02-02 
$19,623,652.00 
$25,000,000.00 
$5,376,348.00 
Equity 
4
2018-06-15 
$21,968,435.00 
$30,966,289.00 
$8,997,854.00 
Equity 
3
2016-05-09 
$23,782,436.00 
$23,782,436.00 
$0.00 
Debt 
2
2015-06-01 
$25,000,073.00 
$25,000,073.00 
$0.00 
Equity, Debt 
1
2014-09-18 
$20,000,000.00 
$20,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES 
 
BARRY 
DIRECTOR
INSPIREMD, INC.   |  ARSENAL MEDICAL, INC.   |  EYEPOINT PHARMACEUTICALS, INC.   |  GRID7 LLC   |  U.S. REAL PROPERTY INCOME FUND, L.P.   |  EXCHANGE PLACE LP   |  REAL ESTATE VALUE ADD LP   |  EXCHANGE PLACE: ALL CAP LP   |  OFFALY GOOD FOODS, INC.   |  PHARMACANN INC.   |  CARDIAC IMPLANTS LLC   |  AGNOVOS BIOSCIENCE, INC.
JAMES 
PATRICK 
BARRY 
DIRECTOR
APPIAN FUND, LLC   |  NEOPHARM PHARMACANN INVESTORS II, LLC   |  APPIAN TWO, LLC   |  PHARMACANN INC.
PATRICK 
 
BARRY 
DIRECTOR
TRICKPLAY INC.   |  DEMANDFORCE INC   |  NAVITUS PARTNERS, LLC   |  VICTORY ENERGY CORP   |  PHARMACANN INC.   |  ENDO, INC.
GREG 
 
CAPPELLI 
DIRECTOR
PHARMACANN INC.
DAVID 
 
CHIOVETTI 
EXECUTIVE OFFICER
PHARMACANN INC.
CHRISTINA 
 
LEJA 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
PHARMACANN LLC
CHRISTINA 
D 
LEJA 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
PHARMACANN LLC
JOHN 
 
LEJA 
EXECUTIVE OFFICER, PROMOTER
PHARMACANN LLC   |  IVIK HOLDINGS LTD.   |  G+G LABORATORIES, INC   |  HUNTINGTON VALLEY VENTURES, INC.
JOHN 
A 
LEJA 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
PHARMACANN LLC
BRAD 
 
LESHNOCK 
EXECUTIVE OFFICER
PHARMACANN LLC   |  NEOPHARM PHARMACANN INVESTORS II, LLC
JOHN 
 
LORD 
DIRECTOR, EXECUTIVE OFFICER
SAVARA INC.   |  LIVWELL HOLDINGS, INC.   |  SAVARA INC   |  PHARMACANN INC.   |  WWCG 347 BROAD, LLC   |  WWCG 215 E HIGH LLC
JOHN 
 
MCCARTHY 
DIRECTOR
GO GROUP LLC   |  EQUITY BANCSHARES INC   |  NASUNI CORP   |  STARWOOD ERE CO-INVEST, L.L.C.   |  SCG HOTEL INVESTORS CL,L.P.   |  CONSQUARE OFFICE REIT, LLC   |  SCG HOTEL INVESTORS N INC.   |  WANDERLUST GROUP, INC.   |  SOF-11 INVESTOR INTERNATIONAL INSTITUTIONAL, SCSP   |  SOF-11 INVESTOR INTERNATIONAL PRIVATE, SCSP   |  SOF-11 INTERNATIONAL, SCSP   |  STARWOOD OPPORTUNITY FUND XI INVESTOR KT, L.P.   |  SOF-XI VIP ONSHORE, L.P.   |  SOF-XI VIP TE, L.P.   |  SOF-XI VIP OFFSHORE, L.P.   |  STARWOOD OPPORTUNITY FUND XI INVESTOR U.S. INSTITUTIONAL MAR, L.P.   |  STARWOOD OPPORTUNITY FUND XI INVESTOR U.S. INSTITUTIONAL NRE, L.P.   |  STARWOOD OPPORTUNITY FUND XI U.S. INSTITUTIONAL SAR, L.P.   |  STARWOOD OPPORTUNITY FUND XI INVESTOR U.S. PRIVATE, L.P.   |  STARWOOD OPPORTUNITY FUND XI U.S. INSTITUTIONAL MAR, L.P.   |  STARWOOD OPPORTUNITY FUND XI U.S. PRIVATE SAR, L.P.   |  STARWOOD OPPORTUNITY FUND XI GLOBAL, L.P.   |  STARWOOD OPPORTUNITY FUND XI U.S. PRIVATE NRE, L.P.   |  STARWOOD OPPORTUNITY FUND XI U.S. INSTITUTIONAL NRE, L.P.   |  STARWOOD OPPORTUNITY FUND XI U.S. INSTITUTIONAL MAR (CF), L.P.   |  STARWOOD OPPORTUNITY FUND XI INVESTOR KA, L.P.   |  1101 NYA REIT INVESTOR (DE) LLC   |  900 16TH STREET REIT INVESTOR (DE) LLC   |  SVF SEAPORT REIT, LLC   |  T-C 501 BOYLSTON STREET LLC   |  STARWOOD REAL ESTATE INCOME TRUST OFFSHORE FUND, SPC   |  PHARMACANN INC.   |  SEASONED 2.0 INC.   |  ORDERFUL INC.   |  OMD REIT, LLC   |  ATTIVA U.S.A., INC.   |  SUB REIT 347 MADISON LLC   |  300 BINNEY SUBREIT LLC   |  CYBERSAINT, INC.   |  290 BINNEY SUBREIT LLC   |  DW SH COMMONS REIT, LLC   |  GLF8 NORDAHL ROAD LLC   |  GLF26 PANAMA ROAD LLC   |  QOZB I INVESTMENT LP
ROBERT 
 
MCQUEEN 
EXECUTIVE OFFICER
PHARMACANN INC.
BRETT 
 
NOVEY 
EXECUTIVE OFFICER, DIRECTOR
PHARMACANN INC.
LORI 
 
RICHARDS 
DIRECTOR
PHARMACANN INC.
DANIEL 
 
ROTH 
EXECUTIVE OFFICER
SHASER, INC   |  PHARMACANN INC.
STEPHEN 
 
SCHULER 
DIRECTOR, EXECUTIVE OFFICER, PROMOTER
PHARMACANN LLC   |  PHARMACANN INC.
STEPHEN 
G 
SCHULER 
DIRECTOR
PHARMACANN LLC
NORAH 
 
SCOTT 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
PHARMACANN LLC
TEDDY 
 
SCOTT 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
PHARMACANN LLC   |  MLH MSO HOLDCO, INC.
TEDDY 
C 
SCOTT 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
PHARMACANN LLC
PATRICK 
 
UNZICKER 
EXECUTIVE OFFICER
PHARMACANN INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-04-09
D
Link
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Debt 
2023-11-06 
2024-04-09
D/A
Link
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Debt 
2023-04-03 
2024-04-09
D
Link
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity, Debt 
2024-03-28 
2024-04-09
D
Link
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Debt 
2023-11-07 
2024-04-09
D
Link
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Debt 
2023-04-27 
2024-04-09
D
Link
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Debt 
2020-05-14 
2024-04-09
D
Link
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Debt 
2023-12-01 
2023-04-05
D
Link
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Debt 
2023-04-03 
2022-11-07
D
Link
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
 
2022-10-31 
2022-07-08
D
Link
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Debt 
2022-06-30 
2021-07-09
D
Link
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Debt 
2021-06-24 
2021-06-25
D
Link
OTHER 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
 
2021-06-14 
2021-03-19
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-05 
2020-11-13
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-10 
2020-09-23
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-10 
2020-05-11
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-02 
2018-07-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-15 
2017-01-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-05-09 
2015-12-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2015-06-01 
2014-10-03
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2014-09-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NETSHARES FINANCIAL SERVICES LLC
307532
NONE
NONE
NETSHARES FINANCIAL SERVICES LLC
307532
CANACCORD GENUITY CORP.
NONE
CANACCORD GENUITY LLC
1020
NONE
NONE
CANACCORD GENUITY, LLC
1020
NONE
NONE
ENTORO SECURITIES, LLC
35192
NONE
NONE
GT SECURITIES, INC.
116012